|

MB04 (proposed biosimilar to etanercept) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • mAbxience Research S.L.1

Indications

  • Rheumatoid Arthritis (RA1
  • Arthritis1

Other1 trial

A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.